Intravenous Esketamine on Prevention of Postoperative Depression in Patients Undergoing Cardiac Surgery

  • STATUS
    Recruiting
  • days left to enroll
    78
  • participants needed
    80
  • sponsor
    Anshi Wu
Updated on 22 December 2021

Summary

Esketamine is a general anesthetic with anti-depressant effects at subanaesthetic doses. This study hypothesized that intraoperative administration of ketamine would prevent or mitigate postoperative depressive symptoms in surgical patients.

Description

Single subanaesthetic doses of i.v. esketamine may significantly improve symptoms in psychiatric patients with major depression.

In patients undergoing cardiac surgery, postoperative depressive symptoms are common.

This study hypothesizes that low-dose esketamine has a preventive effect on postoperative depression. However, evidence in this aspect is insufficient. The purpose of this study is to investigate the effect of a subanaesthetic dose of ketamine on POD for patients undergoing cardiac surgery.

Details
Condition Postoperative Depression
Treatment Normal saline, Esketamine
Clinical Study IdentifierNCT05155969
SponsorAnshi Wu
Last Modified on22 December 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients scheduled for heart surgery
Moderate to severe depressive symptom measured by the qualified psychiatric doctors
Over 18 years of age
American Society of Anesthesiologists physical status I-III

Exclusion Criteria

History of epilepsy
Major depression disorder patients undergoing antidepressive therapy within 2 weeks
Psychiatric illness
Drug abuse
History of allergy to esketamine
Hyperthyroidism
Patients can not cooperate with investigators on psychiatric assessments
Pregnant or breastfeeding woman
refuse to sign informed consent
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note